Literature DB >> 29719132

Abdominal Subcutaneous Fat: A Favorable or Nonfunctional Fat Depot for Glucose Metabolism in Chinese Adults?

Xuhong Hou1,2,3,4, Peizhu Chen1,2,3,5, Gang Hu4, Li Wei1,2,3,5, Lei Jiao6, Hongmei Wang6, Yebei Liang1,2,3,5, Yuqian Bao1,2,3,5, Weiping Jia1,2,3,5.   

Abstract

OBJECTIVE: The objective of this study was to assess the associations of abdominal visceral and subcutaneous adipose tissue with blood glucose and beta-cell function.
METHODS: In this study, 11,223 participants without known diabetes were selected for this cross-sectional analysis. Visceral and subcutaneous fat area (VFA and SFA) were measured by magnetic resonance imaging. An oral glucose tolerance test was conducted, and beta-cell function was evaluated.
RESULTS: Men had significantly larger VFA but smaller SFA than women. After controlling for age, linear regression showed that SFA was adversely associated with 0-minute, 30-minute, and 2-hour plasma glucose (PG) and early-, first- and second-phase disposition indices (DIs). After further adjustment for BMI and VFA, some associations of SFA with PG indices and DIs disappeared, while the other associations became significantly weaker in men (2-hour PG: 0.05 and DI2nd : -0.05) or were reversed in women (0-minute, 30-minute, and 2-hour PG: from -0.07 to -0.04; DI1st : 0.04, P < 0.05). After adjustment for age, BMI, and SFA, VFA was significantly and adversely associated with PG indices and DIs, with the largest standardized regression coefficients with 2-hour PG.
CONCLUSIONS: The associations of SFA with blood glucose and beta-cell function were clinically insignificant in Chinese adults. VFA had the strongest association with 2-hour PG.
© 2018 The Obesity Society.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29719132      PMCID: PMC9208318          DOI: 10.1002/oby.22183

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   9.298


  26 in total

1.  Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women.

Authors:  M Brochu; R D Starling; A Tchernof; D E Matthews; E Garcia-Rubi; E T Poehlman
Journal:  J Clin Endocrinol Metab       Date:  2000-07       Impact factor: 5.958

Review 2.  Subcutaneous and visceral adipose tissue: structural and functional differences.

Authors:  M Mohsen Ibrahim
Journal:  Obes Rev       Date:  2009-07-28       Impact factor: 9.213

3.  Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans.

Authors:  E J Boyko; W Y Fujimoto; D L Leonetti; L Newell-Morris
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

Review 4.  Review of methods for measuring β-cell function: Design considerations from the Restoring Insulin Secretion (RISE) Consortium.

Authors:  Tamara S Hannon; Steven E Kahn; Kristina M Utzschneider; Thomas A Buchanan; Kristen J Nadeau; Philip S Zeitler; David A Ehrmann; Silva A Arslanian; Sonia Caprio; Sharon L Edelstein; Peter J Savage; Kieren J Mather
Journal:  Diabetes Obes Metab       Date:  2017-06-22       Impact factor: 6.577

5.  High-normal 2 h glucose is associated with defects of insulin secretion and predispose to diabetes in Chinese adults.

Authors:  Ziwei Lin; Jian Zhou; Xiaowen Li; Lige Song; Xuhong Hou; Junling Tang; Chen Wang; Weiping Jia
Journal:  Endocrine       Date:  2014-04-08       Impact factor: 3.633

6.  Abdominal adiposity and insulin resistance in obese men.

Authors:  Robert Ross; James Aru; Jennifer Freeman; Robert Hudson; Ian Janssen
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-03       Impact factor: 4.310

7.  Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.

Authors:  D R Matthews; J P Hosker; A S Rudenski; B A Naylor; D F Treacher; R C Turner
Journal:  Diabetologia       Date:  1985-07       Impact factor: 10.122

8.  Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study.

Authors:  Caroline S Fox; Joseph M Massaro; Udo Hoffmann; Karla M Pou; Pal Maurovich-Horvat; Chun-Yu Liu; Ramachandran S Vasan; Joanne M Murabito; James B Meigs; L Adrienne Cupples; Ralph B D'Agostino; Christopher J O'Donnell
Journal:  Circulation       Date:  2007-06-18       Impact factor: 29.690

9.  Fat distribution and glucose intolerance among Greenland Inuit.

Authors:  Marit Eika Jørgensen; Knut Borch-Johnsen; Ronald Stolk; Peter Bjerregaard
Journal:  Diabetes Care       Date:  2013-05-08       Impact factor: 19.112

10.  Associations between ultrasound measures of abdominal fat distribution and indices of glucose metabolism in a population at high risk of type 2 diabetes: the ADDITION-PRO study.

Authors:  Annelotte Philipsen; Marit E Jørgensen; Dorte Vistisen; Annelli Sandbaek; Thomas P Almdal; Jens S Christiansen; Torsten Lauritzen; Daniel R Witte
Journal:  PLoS One       Date:  2015-04-07       Impact factor: 3.240

View more
  3 in total

1.  An association between visceral or subcutaneous fat accumulation and diabetes mellitus among Japanese subjects.

Authors:  Hirohide Yokokawa; Hiroshi Fukuda; Mizue Saita; Kento Goto; Tengen Kaku; Taiju Miyagami; Yuichi Takahashi; Chieko Hamada; Teruhiko Hisaoka; Toshio Naito
Journal:  Diabetol Metab Syndr       Date:  2021-04-14       Impact factor: 3.320

2.  Magnetic Resonance Imaging Assessment of Abdominal Ectopic Fat Deposition in Correlation With Cardiometabolic Risk Factors.

Authors:  Qin-He Zhang; Lu-Han Xie; Hao-Nan Zhang; Jing-Hong Liu; Ying Zhao; Li-Hua Chen; Ye Ju; An-Liang Chen; Nan Wang; Qing-Wei Song; Li-Zhi Xie; Ai-Lian Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-30       Impact factor: 5.555

3.  FGF21/adiponectin ratio predicts deterioration in glycemia: a 4.6-year prospective study in China.

Authors:  Dan Liu; Liang Wu; Qiongmei Gao; Xiaoxue Long; Xuhong Hou; Lingling Qian; Jiacheng Ni; Qichen Fang; Huating Li; Weiping Jia
Journal:  Cardiovasc Diabetol       Date:  2021-07-28       Impact factor: 9.951

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.